Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy

T Inamoto, H Matsuyama, N Ibuki, K Komura… - The Journal of …, 2018 - Elsevier
Purpose In patients with urothelial carcinoma CIS (carcinoma in situ) generally has a poor
prognosis. However, to our knowledge the outcomes of pure/primary CIS and the behavior …

[HTML][HTML] Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma

M Metcalf, PM Pierorazio - Translational Andrology and Urology, 2020 - ncbi.nlm.nih.gov
Though radical nephroureterectomy remains the gold standard treatment for high grade or
invasive disease in upper tract urothelial cancer (UTUC), kidney-sparing surgery has …

Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette–Guérin for the treatment of upper tract carcinoma in situ

IM McElree, SL Mott, HY Hougen, VT Packiam… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction Nephroureterectomy is commonly performed for high-grade (HG) upper tract
(UT) urothelial carcinoma (UC). However, some patients may benefit from a de-escalation of …

Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens: Recommendations From the …

H Samaratunga, M Judge, B Delahunt… - The American journal …, 2019 - journals.lww.com
Cancer reporting guidelines have been developed and utilized in many countries
throughout the world. The International Collaboration on Cancer Reporting (ICCR), through …

Minimally invasive therapy for upper tract urothelial cell cancer

S Pan, AD Smith, P Motamedinia - Journal of Endourology, 2017 - liebertpub.com
Minimally invasive therapy for upper tract urothelial cell cancer has assumed an important
role in the management of this relatively uncommon genitourinary malignancy. In this …

The Role of Local Agents for the Treatment of Localized Upper Tract Urothelial Carcinoma: A Review of the Current Evidence

AD Asimakopoulos, M Kochergin, C Klöcker… - Bladder …, 2023 - content.iospress.com
Kidney-sparing surgery (KSS) for upper urinary tract urothelial carcinoma (UTUC) is a
promising alternative to radical nephroureterectomy, especially for low-risk cases. However …

Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis

H Zhou, Y Pan, M Xu, S Wang, Y Li, X Liu - Urology Journal, 2023 - ojs3.sbmu.ac.ir
Purpose: Intracavitary chemotherapy is one of the current treatment options for kidney-
sparing treatment of upper tract urothelial carcinoma (UTUC). The purpose of this meta …

Upper tract urothelial carcinoma

KD Linton, JWF Catto - Journal of Clinical Urology, 2013 - journals.sagepub.com
Upper tract urothelial carcinoma (UTUC) accounts for approximately 5% of all urothelial
carcinoma. There are many risk factors for UTUC, including environmental and genetic risk …

[HTML][HTML] Contemporary management of upper tract urothelial cell carcinoma

K Choi, R McCafferty, S Deem - World Journal of Clinical Urology, 2017 - wjgnet.com
Upper tract urothelial cell carcinoma (UTUCC), formerly known as transitional cell carcinoma
of the upper urinary tract, is a rare oncologic disease in Western countries. Thus its disease …

Manejo del carcinoma in situ de tramo urinario superior diagnosticado por biopsia ureteroscópica:¿ es el bacilo de Calmette-Guérin una alternativa a la …

A Territo, S Fontanet, I Meneghetti, A Gallioli… - Actas Urológicas …, 2023 - Elsevier
Introducción La nefroureterectomía radical (NFU) es el tratamiento estándar del carcinoma
de tramo urinario superior (TUS). No obstante, desde 1985 se ha introducido el tratamiento …